Money related,Spotlight Stock,Wallstreet420 StocksThe Next Life-Changing Cannabinoid Success story has gone mainstream and one biopharma is set to dominateby Steven Hansen May 15, 2017 Is Marijuana the next Antibiotic? As early as 10 years ago, it was discovered that Cannabinoids harvested from cannabis plants could possibly surpass conventional antibiotics in the escalating war against drug-resistant bacteri...
Money related,Spotlight Stock,Wallstreet420 StocksTHIS ONE UNDISCOVERED POT STOCK COULD HELP INVESTORS CASH IN ON THE “GREEN GOLD RUSH”by Steven Hansen May 08, 2017 One Company – the First of its Kind in the World – Offers Investors the Best Way to Play the Massive Growth in Legal Marijuana Revealed: Why Investors Should Watch Shares of Cannabis Wheaton (TSX.V - CBW) ; (OTC - KWFLF) Cl...
Wallstreet420 StocksThe World's First Marijuana ETF Is Finally Hereby Sophie Vida May 05, 2017It's been exciting times for Canada as the country plans to legalize marijuana by next year. Last month the country saw the world's first cannabis-related exchange-traded fund start trading on the Toronto Stock Exchange. It's ca...
Wallstreet420 StocksShould Investors Be Worried About These Three Cannabis Stocks?by Steven Hansen May 02, 2017There are a number of firms which depend on Marijuana Inc. (NASDAQ: NJNA) as raw material for its medical processes. These companies include GW Pharmaceuticals (NASDAQ: GWPH), Aurora Cannabis (NASDAQ:ACBFF) and Axim Biotechnologie...
Wallstreet420 StocksCanopy Growth Corporation Launches Its First-In-Class Craft Grow Programby Sophie Vida May 01, 2017Canopy Growth Corporation announced last month that it has launched its first-in-class Craft Grow program that allows access to genetics, knowledge, and retail infrastucture to strategic partners. The newly formed company, Canopy...
Wallstreet420 StocksGW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) Epidiolex® Gets Orphan Drug Designationby Steven Hansen April 18, 2017GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) reported that its drug Epidiolex® has received Orphan Drug Designation from the European Medicines Agency. This status is granted in respect to the drug targeting Lennox-Gastaut Syndrome....
Featured,Wallstreet420 StocksCannabis Science Inc (OTCMKTS:CBIS) Subsidiary Buys Majority Shares of Jinvatorby Steven Hansen April 13, 2017Cannabis Science Inc (OTCMKTS:CBIS) Subsidiary Buys Majority Shares of Jinvator Cannabis Science Inc (OTCMKTS:CBIS) reported that its subsidiary firm Cannabis Science Europe GmbH has acquired almost 75% of Jinvator Bio Med GmbH. C...
Wallstreet420 StocksMedical Marijuana Inc (OTCMKTS:MJNA) Updates On Term Sheet Deal With U.S. API Companyby Steven Hansen April 13, 2017Medical Marijuana Inc (OTCMKTS:MJNA) reported that its major investment firm Axim Biotechnologies Inc (OTCMKTS:AXIM) has finalized a Term Sheet Deal with an active pharmaceutical ingredient production firm to advance a chewing gum...
